2019
DOI: 10.1016/j.radonc.2019.04.025
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
38
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(45 citation statements)
references
References 29 publications
5
38
2
Order By: Relevance
“…Previous literatures reported approximately 90% local control rates for NPC in the IMRT era [27,28]. Due to recent advances in RT technology, no observed associated differences in LRRFS between patients in high RWL and low RWL groups were found in the present study.…”
Section: Discussioncontrasting
confidence: 43%
“…Previous literatures reported approximately 90% local control rates for NPC in the IMRT era [27,28]. Due to recent advances in RT technology, no observed associated differences in LRRFS between patients in high RWL and low RWL groups were found in the present study.…”
Section: Discussioncontrasting
confidence: 43%
“…Our study results were consistent with the findings of studies conducted in numerous endemic areas. 7,8 Type A tumors were more likely to recur, and type D tumors were more likely to metastasize. In endemic areas, patients with type D tumors have a worse 5-year OS than patients with type A tumors.…”
Section: Discussionmentioning
confidence: 99%
“…We expect tumors to respond after receiving the treatment, however, it is not uncommon for the "best treatment plan" to yield poor results. Radiotherapy resistance, recurrence, distant metastasis, and complications caused by radiotherapy are analyzed and considered in many studies as the main causes of treatment failure and patient death (37)(38)(39)(40). Oncologists could adjust the predetermined treatment plan according to the obtained evidence to match the estimated tumor risk.…”
Section: Discussionmentioning
confidence: 99%